Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,027Revenue $M512Net Margin (%)19.8Z-Score9.5
Enterprise Value $M1,637EPS $1.5Operating Margin %-1.3F-Score4
P/E(ttm))1,072Cash Flow Per Share $1.3Pre-tax Margin (%)28.7Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %0Quick Ratio4.7Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %4.1Current Ratio5.3Lower Leverage y-yN
Price/Cash Flow16.5y-y EBITDA Growth Rate %-89.1ROA % (ttm)10.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)12.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M70.1ROI % (ttm)18.6Gross Margin Increase y-yN

Gurus Latest Trades with IPXL

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IPXLJohn Hussman 2014-03-31 Buy 0.44%$22.02 - $27.91
($24.94)
$ 28.9416%New holding, 220000 sh.220,000
IPXLJohn Hussman 2012-03-31 Sold Out -0.11%$18.64 - $24.37
($20.72)
$ 28.9440%Sold Out0
IPXLJoel Greenblatt 2012-03-31 Sold Out -0.05%$18.64 - $24.37
($20.72)
$ 28.9440%Sold Out0
IPXLJoel Greenblatt 2011-12-31 Reduce-0.47%$16.53 - $20.75
($18.65)
$ 28.9455%Reduce -88.51%21,057
IPXLJoel Greenblatt 2011-09-30 Reduce-0.38%$15.26 - $21.56
($19.54)
$ 28.9448%Reduce -40.22%183,187
IPXLJoel Greenblatt 2011-06-30 Add0.76%$20.21 - $28.73
($25.28)
$ 28.9414%Add 446.09%306,452
IPXLGeorge Soros 2011-06-30 Sold Out $20.21 - $28.73
($25.28)
$ 28.9414%Sold Out0
IPXLJohn Hussman 2011-03-31 Add0.02%$20.11 - $25.52
($22.84)
$ 28.9427%Add 20.21%339,000
IPXLGeorge Soros 2011-03-31 Reduce$20.11 - $25.52
($22.84)
$ 28.9427%Reduce -41.13%13,600
IPXLJoel Greenblatt 2011-03-31 Reduce-1.55%$20.11 - $25.52
($22.84)
$ 28.9427%Reduce -78.32%56,118
IPXLJoel Greenblatt 2010-12-31 Buy 1.7%$17.91 - $21.86
($19.9)
$ 28.9445%New holding, 258801 sh.258,801
IPXLJohn Hussman 2010-12-31 Add0.06%$17.91 - $21.86
($19.9)
$ 28.9445%Add 176.47%282,000
IPXLGeorge Soros 2010-12-31 Buy 0.01%$17.91 - $21.86
($19.9)
$ 28.9445%New holding, 23100 sh.23,100
IPXLJohn Hussman 2010-09-30 Buy 0.03%$15.63 - $19.79
($17.38)
$ 28.9466%New holding, 102000 sh.102,000
IPXLGeorge Soros 2010-06-30 Sold Out $16.66 - $21.62
($19.29)
$ 28.9450%Sold Out0
IPXLGeorge Soros 2010-03-31 Buy $13 - $18.05
($14.93)
$ 28.9494%New holding, 17400 sh.17,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IPXL is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
IPXL John Hussman 2014-03-31220,0000.310.44New Buy
Premium Most recent portfolio changes are included for Premium Members only!


IPXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HSU LARRYDirector 2014-06-06Sell100,000$28.381.97view
TERRERI PETER RDirector 2014-05-27Sell3,000$283.36view
HSU LARRYDirector 2014-05-22Sell50,000$27.226.32view
HSU LARRYDirector 2014-05-21Sell3,800$26.539.08view
TERRERI PETER RDirector 2014-05-20Sell666$26.0711.01view
TERRERI PETER RDirector 2014-05-19Sell950$26.0311.18view
FLEMING NIGELDirector 2014-05-16Sell1,900$25.7212.52view
TERRERI PETER RDirector 2014-05-13Sell666$26.78.39view
FLEMING NIGELDirector 2014-05-12Sell1,333$26.588.88view
MARKBREITER MICHAELDirector 2014-05-08Sell12,500$26.449.46view

Press Releases about IPXL :

    Quarterly/Annual Reports about IPXL:

    News about IPXL:

    Articles On GuruFocus.com
    comment on IPXL Sep 24 2012 
    President and CEO of Impax Laboratories Inc. (IPXL) Larry Hsu Bought 10,000 Shares Aug 17 2011 
    Impax Laboratories Inc. (IPXL) CEO Larry Hsu buys 5,000 Shares Aug 12 2010 
    Impax Laboratories Inc. (IPXL) CEO Larry Hsu buys 10,000 Shares Aug 12 2010 
    Impax Laboratories Reports Second Quarter 2009 Financial Results Aug 04 2009 

    More From Our Partners
    Why Lannett Shares Are Down More Than 16% Jul 16 2014 - BENZINGA

    More From Other Websites
    Impax Laboratories (IPXL): Strong Industry, Solid Earnings Estimate Revisions Jul 16 2014
    Impax Labs get subpoena in price fixing probe Jul 15 2014
    IMPAX LABORATORIES INC Files SEC form 8-K, Other Events Jul 15 2014
    Impax Acquires Generic Products from Actavis Jul 03 2014
    Impax Acquires Two Products from Actavis Jul 02 2014
    Impax Acquires Two Products from Actavis Jul 02 2014
    Trade-Ideas: Impax Laboratories (IPXL) Is Today's New Lifetime High Stock Jul 01 2014
    Impax Laboratories to Announce Results for Second Quarter 2014 on August 6 Jul 01 2014
    Impax Laboratories to Announce Results for Second Quarter 2014 on August 6 Jul 01 2014
    Today In SA PRO: Monday, June 23 Jun 24 2014
    U.S. Steps Up Probes of Deals to Block Generic Drugs Jun 22 2014
    Generic-Drug Makers Climb Ranks; Several In Buy Range Jun 20 2014
    Impax to Present at Goldman Sachs 35th Annual Global Healthcare Conference Jun 06 2014
    Coverage initiated on Impax Labs by WallachBeth Jun 06 2014
    Insider Trading Alert - AINV, IPXL And MCK Traded By Insiders May 29 2014
    Insider Trading Alert - CHRW, IPXL And ALOG Traded By Insiders May 27 2014
    Today In SA PRO: Friday, May 23 May 24 2014
    Insider Trading Alert - IPXL, ALOG And EA Traded By Insiders May 23 2014
    Insider Trading Alert - IPXL, OKE And OXY Traded By Insiders May 22 2014
    Insider Trading Alert - ARP, AKRX And IPXL Traded By Insiders May 20 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide